Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Credit

<ul><li>Estee Lauder's business might have a relatively weak perception today as it has suffered from the pandemic and also faces the impact of the macro-economic headwinds, increasing interest rates, and the rising geopolitical tensions affecting broader markets.</li><li>The company’s previous result was not too bad with organic sales growth having driven a 20% increase in reported sales.</li><li>Based on our credit analysis, the company merits a Credit Evaluation Score of A with a stable outlook and as per our Financial Strength Indicator, its performance is 4.19/ 5.</li></ul>

Estee Lauder's business might have a relatively weak perception today as it has suffered from the pandemic and also faces the impact of the macro-economic headwinds, increasing interest rates, and the rising geopolitical tensions affecting broader markets.The company’s previous result was not too bad with organic sales growth having driven a 20% increase in reported sales.Based on our credit analysis, the company merits a Credit Evaluation Score of A with a stable outlook and as per our Financial Strength Indicator, its performance is 4.19/ 5.

Estee Lauder: Detailed Credit Analysis & Financial Strength Evaluation Report

Equity Capital Markets

Estee Lauder Companies Cl A / Equity Capital Markets

<ul><li>Estee Lauder’s stock price has gone through a strong correction over the past few weeks on account of the macro-economic headwinds, increasing interest rates, and the rising geopolitical tensions affecting broader markets.</li><li>The company’s last quarterly result was not too bad with organic sales growth having driven a 20% increase in reported sales.</li><li>Eleven of the company’s brands saw double-digit organic sales growth in the last quarter with key brands such as Clinique, Estee Lauder, La Mer, and M.A.C., continuing to gain traction.</li></ul>

Estee Lauder’s stock price has gone through a strong correction over the past few weeks on account of the macro-economic headwinds, increasing interest rates, and the rising geopolitical tensions affecting broader markets.The company’s last quarterly result was not too bad with organic sales growth having driven a 20% increase in reported sales.Eleven of the company’s brands saw double-digit organic sales growth in the last quarter with key brands such as Clinique, Estee Lauder, La Mer, and M.A.C., continuing to gain traction.

Estee Lauder: Financial & Price Forecasts

<ul><li>Estée Lauder delivered an excellent performance and started its 2022 fiscal by reinforcing investor optimism in future opportunities.</li><li>On the other hand, its Mac brand strategically engaged consumers to drive makeup performance.</li><li>We give Estée Lauder a 'Hold' rating with a revised target price.</li></ul>

Estée Lauder delivered an excellent performance and started its 2022 fiscal by reinforcing investor optimism in future opportunities.On the other hand, its Mac brand strategically engaged consumers to drive makeup performance.We give Estée Lauder a 'Hold' rating with a revised target price.

Estee Lauder Companies Inc. - Investment Thesis

Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

FSN E-commerce (Nykaa) aims to raise around US$720m, via selling a mix of primary and secondary shares in its Indian IPO. Nykaa is a lifestyle focussed e-commerce platform and consumer brand offering a portfolio of beauty, personal care and fashion products, including its own branded products. As per RedSeer, it was the largest Specialty Beauty and Personal Care Platform in India in terms of value of products sold in FY21.As of March 21, it had 43.7m cumulative downloads across all its mobile applications. Its offline channel comprises 73 physical stores across 38 cities in India. It reported a gross merchandise value (GMV) of INR40,459.8m (around US$550m) in FY21. Nykaa’s GMV, revenue and gross profit have more than doubled over FY19-21, even though the company suffered from a drop in orders due to COVID-19 in 4Q20 and 1Q21. Overall, GMV grew by 62.7% in FY20 and 50.7% in FY21. Revenue growth has broadly kept pace with GMV growth while the company has managed to turn a profit in FY21. We have looked at various aspects of the deal in our previous note,<a href="https://www.smartkarma.com/insights/fsn-e-commerce-nykaa-pre-ipo-mixed-bag-fashion-growing-beauty-slowing" target="_blank" rel="noopener"> FSN E-Commerce (Nykaa) Pre-IPO - Mixed bag - Fashion growing, beauty slowing</a>. In this note, we will talk about valuations.

FSN E-commerce (Nykaa) aims to raise around US$720m, via selling a mix of primary and secondary shares in its Indian IPO. Nykaa is a lifestyle focussed e-commerce platform and consumer brand offering a portfolio of beauty, personal care and fashion products, including its own branded products. As per RedSeer, it was the largest Specialty Beauty and Personal Care Platform in India in terms of value of products sold in FY21.As of March 21, it had 43.7m cumulative downloads across all its mobile applications. Its offline channel comprises 73 physical stores across 38 cities in India. It reported a gross merchandise value (GMV) of INR40,459.8m (around US$550m) in FY21. Nykaa’s GMV, revenue and gross profit have more than doubled over FY19-21, even though the company suffered from a drop in orders due to COVID-19 in 4Q20 and 1Q21. Overall, GMV grew by 62.7% in FY20 and 50.7% in FY21. Revenue growth has broadly kept pace with GMV growth while the company has managed to turn a profit in FY21. We have looked at various aspects of the deal in our previous note, FSN E-Commerce (Nykaa) Pre-IPO - Mixed bag - Fashion growing, beauty slowing. In this note, we will talk about valuations.

FSN E-Commerce (Nykaa) IPO - Beauty Showing Signs of Improvement but Its Too Expensive for Our Taste

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Independent Stock Specific Research

BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Equity Bottom-Up

<ul type="disc"><li>
Inter Parfums (IPAR) announced it has signed a license to develop and sell fragrances under the Donna Karan and DKNY brands beginning in the second half of 2022. This is the second license win IPAR has announced in the last six months, the prior being Salvatore Ferragamo.</li></ul> <ul type="disc"><li>IPAR won the Donna Karan license away from Estee Lauder (EL) who had been the exclusive licensee since the inception of the brand’s fragrance line. IPAR’s license would begin on July 1, 2022 by taking over the fragrances already on the market.</li></ul> <ul type="disc"><li>IPAR’s stock has always received a relatively high valuation due to the steady growth the business has experienced in the past. The addition of Donna Karan should have a positive contribution to earnings in 2022 and 2023 and is not being fully considered in the consensus estimates nor in the current valuation.</li></ul>


Inter Parfums (IPAR) announced it has signed a license to develop and sell fragrances under the Donna Karan and DKNY brands beginning in the second half of 2022. This is the second license win IPAR has announced in the last six months, the prior being Salvatore Ferragamo. IPAR won the Donna Karan license away from Estee Lauder (EL) who had been the exclusive licensee since the inception of the brand’s fragrance line. IPAR’s license would begin on July 1, 2022 by taking over the fragrances already on the market. IPAR’s stock has always received a relatively high valuation due to the steady growth the business has experienced in the past. The addition of Donna Karan should have a positive contribution to earnings in 2022 and 2023 and is not being fully considered in the consensus estimates nor in the current valuation.

United States

The Estee Lauder Companies Inc. manufactures and markets a wide range of skin care, makeup, fragrance, and hair care products.  The Company's products are sold in countries and territories around the world.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Estee Lauder Companies Cl A (EL US)

Estee Lauder: Detailed Credit Analysis & Financial Strength Evaluation Report

Estee Lauder's business might have a relatively weak perception today as it has suffered from the pandemic and also faces the impact of the...

Baptista Research

Estee Lauder: Financial & Price Forecasts

Estee Lauder’s stock price has gone through a strong correction over the past few weeks on account of the macro-economic headwinds, increasing...

Baptista Research

Estee Lauder Companies Inc. - Investment Thesis

Estée Lauder delivered an excellent performance and started its 2022 fiscal by reinforcing investor optimism in future opportunities. On the other...

Baptista Research

FSN E-Commerce (Nykaa) IPO - Beauty Showing Signs of Improvement but Its Too Expensive for Our Taste

FSN E-commerce (Nykaa) aims to raise around US$720m in its Indian IPO. In this note, we will look at the recent updates and valuation.

Sumeet Singh

IPAR: License to Expand

IPAR winning the license to make fragrances for Donna Karan and DKNY brands is significant. The Company is anticipating Donna Karan to become a...

BWS Financial Inc

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)